Legacy Advisors’s Hologic HOLX Stock Holding History

Legacy Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-80	Closed	-$3K	–	414
2017 Q4	$3K	Buy	+80	New	+$3.19K	﹤0.01%	314

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Legacy Advisors's HOLX Position: Q1 2018 in Review

Legacy Advisors sold out of Hologic (HOLX) in Q1 2018, closing a stake of 80 shares — an estimated $3K sold.

Legacy Advisors first reported a position in HOLX in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 462 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

Legacy Advisors reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
Legacy Advisors sold 80 Hologic shares in Q1 2018, an estimated $3K.
Legacy Advisors first reported a position in Hologic in Q4 2017 and held it in 1 quarter.
Legacy Advisors's Hologic position peaked at $3K in Q4 2017.
462 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on Legacy Advisors's 13F filing for Q1 2018, filed 17 Apr 2018.